REYVOW (lasmiditan) tablets, for oral use, [CV in USA] - FOR EXPORT ONLY Initial U.S. Approval: 2020

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY

NDC 0002-0265-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 50 mg

For oral use.

Each tablet contains 50 mg of lasmiditan.

Rx only

50 mg

Dispense enclosed Medication Guide to each patient.

Lilly

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY

NDC 0002-0632-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 100 mg

For oral use.

Each tablet contains 100 mg of lasmiditan.

Rx only

100 mg

Dispense enclosed Medication Guide to each patient.

Lilly